Tuesday, 16 Aug 2022

Medications

At a Tennessee Crossroads, Two Pharmacies, a Monkey, and Millions of Pills

CELINA, Tenn. — It was about 1 a.m. on April 19, 2016, when a burglary alarm sounded at Dale Hollow Pharmacy in Celina, a tiny town in the rolling, wooded hills near the Kentucky border. Two cops responded. As their flashlights bobbed in the darkness, shining through the pharmacy windows, they spotted a sign of […]

FDA Approves Welireg

FDA Approves Welireg (belzutifan) for the Treatment of Patients With Certain Types of Von Hippel-Lindau (VHL) Disease-Associated Tumors KENILWORTH, N.J.–(BUSINESS WIRE) August 13, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Welireg, an oral hypoxia-inducible factor-2 alpha […]

FDA Approves Saphnelo

FDA Approves Saphnelo (anifrolumab) for Moderate to Severe Systemic Lupus Erythematosus 2 August 2021 — AstraZeneca’s Saphnelo (anifrolumab-fnia) has been approved in the US for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE) who are receiving standard therapy.1 The approval by the Food and Drug Administration (FDA) was based on […]

FDA Approves Bristol Myers Squibb’s Zeposia (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

PRINCETON, N.J.–(BUSINESS WIRE) May 27, 2021 — Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).1 Zeposia, an oral medication taken once daily, is the first […]

FDA Approves Rybrevant

FDA Approves Rybrevant (amivantamab-vmjw) as the First Targeted Treatment for Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations May 21, 2021 (HORSHAM, P.A.) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) has granted the accelerated approval of Rybrevant (amivantamab-vmjw) for the […]

CVS y Walgreens desperdician cerca de 130,000 dosis de vacunas contra covid

Dos cadenas de farmacias nacionales en las que el gobierno federal confió para vacunar a las personas contra covid-19 representan la mayor parte de las dosis de vacunas desperdiciadas, según datos del gobierno obtenidos por KHN. Los Centros para el Control y la Prevención de Enfermedades (CDC) registraron 182,874 dosis desperdiciadas a fines de marzo, […]

KHN’s ‘What the Health?’: 100 Days of Health Policy

Can’t see the audio player? Click here to listen on SoundCloud. It’s been a busy 100 days for the Biden administration on health policy. The promise Joe Biden made as president-elect to get 100 million covid vaccinations in arms was doubled, healthcare.gov reopened to those without insurance, and steps were taken to undo a raft of […]

Recent Posts